The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The hidden burden: Quantifying administrative time costs and distress for patients with metastatic breast or advanced stage ovarian cancer.
 
Helen Parsons
No Relationships to Disclose
 
Patricia Jewett
No Relationships to Disclose
 
Katherine Brown
No Relationships to Disclose
 
Alyssa Pecoraro
No Relationships to Disclose
 
Indya Starks
No Relationships to Disclose
 
Stacey Ingram
No Relationships to Disclose
 
Zuofu Huang
Stock and Other Ownership Interests - Walgreens Boots Alliance
 
Arjun Gupta
Employment - Genentech/Roche (I)
 
Deanna Teoh
Honoraria - Asieris Pharmaceuticals
Research Funding - Daiichi Sankyo (Inst); Jounce Therapeutics (Inst); Moderna Therapeutics (Inst); Tesaro/GSK (Inst)
 
Yingling Fan
Other Relationship - daynamica, inc.
 
Anne Blaes
Research Funding - Dompé Farmaceutici
 
Rebecca Arend
Employment - Signatera (I)
Consulting or Advisory Role - 92 Biotech; Caris Life Sciences; Daiichi Sankyo/Lilly; GlaxoSmithKline; KIYATEC; Leap Therapeutics; Merck; Seagan; VBL Therapeutics
Research Funding - Champions Oncology; Exelixis; GlaxoSmithKline; Immunogen; Merck
Travel, Accommodations, Expenses - Caris Life Sciences; GlaxoSmithKline; VBL Therapeutics
 
Gabrielle Rocque
Employment - Atlas Oncology Partners
Consulting or Advisory Role - Atlas Oncology Partners; Atlas/Rubicon (Inst); Atlas/Rubicon (Inst); Gilead Sciences; Pfizer
Research Funding - Daiichi Sankyo/Astra Zeneca; Genentech; Gilead Sciences; Pfizer
 
Julian Wolfson
Other Relationship - Daynamica, Inc
 
Rachel Vogel
Patents, Royalties, Other Intellectual Property - USP14 as a biomarker for endometrial cancer (Inst)